Articles
2026 Saudi Healthcare M&A · Top Transactions & Themes ⓘ Verified top‑20 ranking not publicly available — below are the definitive 2025–2026 transactions and consolidation drivers shaping the Kingdom’s healthcare M&A landscape. Strategic Moves & Key…
consolidation;M@A;Mergers;Acquistion;Egypt;Opportunities
From Individual Assets to Integrated Healthcare Platforms Egypt may be entering an important new chapter in healthcare M&A. For years, the Egyptian healthcare investment story was largely built around individual hospitals, diagnostic centres, pharmaceutical companies and…
Health Industry Practices
Healthcare Deals Reshaping the Middle East & Africa M&A Healthcare Radar | August 2026 The Deal Signal: Healthcare Capital Is Moving From Expansion to Consolidation The healthcare M&A landscape is entering a more strategic phase.…
Business of Health
First-Half Performance, Challenges and Growth Potential in Egypt and the Middle East From Egypt’s Leading Private Hospital Platform to a Potential Regional Healthcare Champion Cleopatra Hospitals Group (CHG) enters the second half of 2026 from a…
Biopharma
Saudi Healthcare Listed Market | August 2026 August 2026 has been an important month for Saudi Arabia’s listed healthcare market. Financial results, operational developments and new contracts announced during the month provide valuable insight into the…
Biopharma
A roundup of key developments in the Saudi listed healthcare sector for the month of August 2026. 📰 1. Avalon Pharma Signs Major Biosimilar Deal Middle East Pharmaceutical Industries Co. (Avalon Pharma) announced a strategic agreement…
Business of Health
Elevate Capital & Moharram Family Acquire Nile Scan and Labs in EGP 1bn Deal July 21, 2026 · Cairo, Egypt In a move that could redefine private diagnostic services in Egypt, Elevate Capital and the Moharram…
Chat with us
We typically reply within a few hours during business days.
